Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Azithromycin is a new antibiotic with a broad spectrum of activity against several different types of antimicrobial pathogens. It has become established for the treatment of common bacterial infections in temperate countries but its role for treating or preventing classical tropical infections is evolving. Azithromycin had reasonable but insufficient prophylactic efficacy against Plasmodium falciparum and limited data currently exist on its use in combination with other antimalarial drugs for treating patients with P. Falciparum malaria. Azithromycin has been used with good results for treating bacillary dysentery, scrub typhus and typhoid fever. Given the global emergence of drug resistance to commonly used antimicrobial agents, more work needs to be done to further define potential use of azithromycin.


Journal article


Giornale Italiano di Medicina Tropicale

Publication Date





15 - 20